JESSICA LUCERO: Open Payments
NPI 1982217089 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 51 payments from 19 companies in 2025. Trend: 2023 $2,018 · 2024 $1,215 · 2025 $1,661
Food & beverage: $1,439Education: $222
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $268 |
| Sumitomo Pharma America, Inc. | 10 | $244 |
| Calyxo, Inc. | 3 | $230 |
| Astellas Pharma US Inc | 2 | $222 |
| Dendreon Pharmaceuticals LLC | 7 | $191 |
| ABBVIE INC. | 6 | $135 |
| Boston Scientific Corporation | 1 | $78 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $45 |
| PFIZER INC. | 2 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
Products named: GEMTESA, CVAC ASPIRATION SYSTEM, PROVENGE, RYBREVANT, ERLEADA, LUPRON DEPOT, Axonics, PYLARIFY.
Industry payments across WA — which companies pay providers there.
